FOLFIRINOX versus gemcitabine nab-paclitaxel for advanced pancreatic cancer: KU Cancer Center experience.

被引：4
|
作者：
Kasi, Anup
Middinti, Akshay
Cao, An
Vekaria, Pratikkumar
Patel, Devangi
Subramaniam, Dipti
Chen, Guoqing J.
Saeed, Anwaar Mohammed
Paluri, Ravi Kumar
机构：
[1] Univ Kansas, Canc Ctr, Westwood, KS USA
[2] Univ Kansas, Kansas City, KS USA
[3] Univ Kansas, Med Ctr, Merriam, KS USA
[4] Univ Alabama Birmingham, Birmingham, AL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e15744
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15744
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Gemcitabine/Nab-Paclitaxel versus FOLFIRINOX in Locally Advanced Pancreatic Cancer: A European Multicenter Study
    Williet, Nicolas
    Petrillo, Angelica
    Roth, Gael
    Ghidini, Michele
    Petrova, Mila
    Forestier, Julien
    Lopez, Anthony
    Thoor, Audrey
    Weislinger, Lucie
    De Vita, Ferdinando
    Taieb, Julien
    Phelip, Jean Marc
    CANCERS, 2021, 13 (11)
  • [2] Offlabel nab-paclitaxel: Gemcitabine chemotherapy in advanced pancreatic cancer-A monoinstitutional experience.
    Lo Re, Giovanni
    Santeufemia, Davide Adriano
    Ius, Antonino
    Del Conte, Alessandro
    Foltran, Luisa
    Fadda, Giovanni Maria
    Basso, Stefano Maria
    Marus, Wally
    Chiara, Giordano Bruno
    Stuto, Angelo
    Tosolini, Giancarlo
    Sulfaro, Sandro
    Spaziante, Roberto
    Nicolosi, Gianluigi
    Boz, Gianni
    Mancinelli, Paolo
    Tumolo, Salvatore
    Bidoll, Ettore
    Cozzi, Cinzia
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [3] Resection rate of locally advanced pancreatic cancer in gemcitabine plus nab-paclitaxel versus FOLFIRINOX.
    Sharif, Shahriar
    Zureikat, Amer H.
    Novelli, Paula M.
    Lopez, Charles D.
    Kardosh, Adel
    Chung, Ki Y.
    Jones, Wesley B.
    Hatoum, Hassan
    Meredith, Kenneth Lee
    Zervos, Emmanuel E.
    Ucar, Antonio
    Gandhi, Ripal T.
    Nazemzadeh, Reza
    Kasi, Pashtoon Murtaza
    Vandestraeten, Erik
    Decaestecker, Jochen
    Delaunoit, Thierry
    Li, Charles Charles
    Agah, Ramtin
    Pishvaian, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [4] FOLFIRINOX for Advanced Pancreatic Cancer Patients After Nab-Paclitaxel Plus Gemcitabine Failure
    Matsumoto, Toshihiko
    Kurioka, Yusuke
    Okazaki, Ukyo
    Matsuo, Yu
    Kimura, Shogo
    Miura, Kou
    Tsuduki, Takao
    Takagi, Shinjiro
    Takatani, Masahiro
    Morishita, Hirofumi
    PANCREAS, 2020, 49 (04) : 574 - 578
  • [5] Gemcitabine plus nab-paclitaxel vs. FOLFIRINOX for patients with advanced pancreatic cancer
    Junko Tahara
    Kyoko Shimizu
    Nao Otsuka
    Junichi Akao
    Yukiko Takayama
    Katsutoshi Tokushige
    Cancer Chemotherapy and Pharmacology, 2018, 82 : 245 - 250
  • [6] Gemcitabine plus nab-paclitaxel vs. FOLFIRINOX for patients with advanced pancreatic cancer
    Tahara, Junko
    Shimizu, Kyoko
    Otsuka, Nao
    Akao, Junichi
    Takayama, Yukiko
    Tokushige, Katsutoshi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (02) : 245 - 250
  • [7] Comparison of gemcitabine plus nab-paclitaxel and FOLFIRINOX in metastatic pancreatic cancer
    Han, Sung Yong
    Kim, Dong Uk
    Seol, Young Mi
    Kim, Suk
    Lee, Nam Kyung
    Hong, Seung Baek
    Seo, Hyung-Il
    WORLD JOURNAL OF CLINICAL CASES, 2020, 8 (17) : 3718 - 3729
  • [8] Comparison of gemcitabine plus nab-paclitaxel and FOLFIRINOX in metastatic pancreatic cancer
    Sung Yong Han
    Dong Uk Kim
    Young Mi Seol
    Suk Kim
    Nam Kyung Lee
    Seung Baek Hong
    Hyung-Il Seo
    World Journal of Clinical Cases, 2020, (17) : 3718 - 3729
  • [9] Folfirinox (FFX) versus gemcitabine with nab-paclitaxel (GNP) in the first line treatment (1LTx) of metastatic pancreatic cancer (mPC): A tertiary center experience.
    Barrera, Ivan
    Hamalova, Sabina
    Ranger, Jill
    Rho, Henry
    Mamo, Aline
    Batist, Gerald
    Kavan, Petr
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [10] Comparison of efficacy and toxicity of FOLFIRINOX and gemcitabine with nab-paclitaxel in unresectable pancreatic cancer
    Muranaka, Tetsuhito
    Kuwatani, Masaki
    Komatsu, Yoshito
    Sawada, Kentaro
    Nakatsumi, Hiroshi
    Kawamoto, Yasuyuki
    Yuki, Satoshi
    Kubota, Yoshimasa
    Kubo, Kimitoshi
    Kawahata, Shuhei
    Kawakubo, Kazumichi
    Kawakami, Hiroshi
    Sakamoto, Naoya
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2017, 8 (03) : 566 - 571
12345